Works matching DE "METAL-ammonia compounds"
Results: 81
Population Pharmacokinetics of Cycloplatam. II. Clinical Monitoring of the Drug Pharmacokinetics Upon Short and Long-Term Infusion.
- Published in:
- Pharmaceutical Chemistry Journal, 2003, v. 37, n. 11, p. 567, doi. 10.1023/B:PHAC.0000016063.69437.c6
- By:
- Publication type:
- Article
The metal–insulator transition and the phase transition in metal–ammonia solutions.
- Published in:
- Journal of Experimental & Theoretical Physics, 1997, v. 84, n. 3, p. 516, doi. 10.1134/1.558170
- By:
- Publication type:
- Article
Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00421
- By:
- Publication type:
- Article
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth.
- Published in:
- Oncogene, 2005, v. 24, n. 40, p. 6080, doi. 10.1038/sj.onc.1208744
- By:
- Publication type:
- Article
A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embyronal carcinoma.
- Published in:
- Oncogene, 2005, v. 24, n. 40, p. 6090, doi. 10.1038/sj.onc.1208755
- By:
- Publication type:
- Article
Inositol 1,4,5-trisphosphate (IP<sub>3</sub>) receptor type1 (IP<sub>3</sub>R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
- Published in:
- Oncogene, 2005, v. 24, n. 8, p. 1396, doi. 10.1038/sj.onc.1208313
- By:
- Publication type:
- Article
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
- Published in:
- Oncogene, 2005, v. 24, n. 6, p. 970, doi. 10.1038/sj.onc.1208316
- By:
- Publication type:
- Article
p12<sup>CDK2-AP1</sup> mediates DNA damage responses induced by cisplatin.
- Published in:
- Oncogene, 2005, v. 24, n. 3, p. 407, doi. 10.1038/sj.onc.1208222
- By:
- Publication type:
- Article
Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.
- Published in:
- Oncogene, 2004, v. 23, n. 42, p. 6997, doi. 10.1038/sj.onc.1207925
- By:
- Publication type:
- Article
Effects of Paclitaxel and Cisplatin on Ovarian Reserves in Rats.
- Published in:
- Erciyes Medical Journal / Erciyes Tip Dergisi, 2008, v. 30, n. 1, p. 024
- By:
- Publication type:
- Article
Cisplatin ototoxicity involves cytokines and STAT6 signaling network.
- Published in:
- Cell Research, 2011, v. 21, n. 6, p. 944, doi. 10.1038/cr.2011.27
- By:
- Publication type:
- Article
Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma.
- Published in:
- Diseases of the Esophagus, 2010, v. 23, n. 8, p. 641, doi. 10.1111/j.1442-2050.2010.01070.x
- By:
- Publication type:
- Article
Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats.
- Published in:
- Kidney International, 1985, v. 28, n. 6, p. 914, doi. 10.1038/ki.1985.217
- By:
- Publication type:
- Article
Conventional vs concomitant boost radiotherapy with concurrent cisplatin in advanced head and neck cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
In vitro release of cisplatin from sol–gel processed organically modified silica xerogels.
- Published in:
- Journal of Materials Science: Materials in Medicine, 2007, v. 18, n. 10, p. 2041, doi. 10.1007/s10856-007-3139-x
- By:
- Publication type:
- Article
Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers.
- Published in:
- Oncology, 2009, v. 76, n. 5, p. 315, doi. 10.1159/000209335
- By:
- Publication type:
- Article
A Randomized Comparative Study of Antiemetic Prophylaxis with Ondansentron in a Single 32-mg Loading Dose versus 8 mg Every 6 h in Patients Undergoing Cisplatin-Based Chemotherapy.
- Published in:
- Oncology, 1998, v. 55, n. 6, p. 513, doi. 10.1159/000011904
- By:
- Publication type:
- Article
Renoprotective Effect of Spirulina fusiformis on Cisplatin-Induced Oxidative Stress and Renal Dysfunction in Rats.
- Published in:
- Renal Failure, 2006, v. 28, n. 3, p. 247, doi. 10.1080/08860220600580399
- By:
- Publication type:
- Article
Salvia Officinalis and Cisplatin Effects on Pentylenetetrazole Induced Seizure Threshold.
- Published in:
- Zahedan Journal of Research in Medical Sciences, 2013, v. 15, n. 11, p. 1
- By:
- Publication type:
- Article
Protective effect of selenium on cisplatin induced nephrotoxicity: A double-blind controlled randomized clinical trial.
- Published in:
- Journal of Nephropathology, 2013, v. 2, n. 2, p. 129, doi. 10.5812/nephropathol.10656
- By:
- Publication type:
- Article
P53 Contributes to Cisplatin Induced Renal Oxidative Damage via Regulating P66shc and MnSOD.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2015, v. 37, n. 4, p. 1240, doi. 10.1159/000430247
- By:
- Publication type:
- Article
Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.
- Published in:
- Journal of Applied Toxicology, 2014, v. 34, n. 2, p. 191, doi. 10.1002/jat.2852
- By:
- Publication type:
- Article
Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats.
- Published in:
- Journal of Applied Toxicology, 2004, v. 24, n. 1, p. 27
- By:
- Publication type:
- Article
Inhibition of autophagy enhances cisplatin-induced apoptosis in the MG63 human osteosarcoma cell line.
- Published in:
- Oncology Letters, 2015, v. 10, n. 5, p. 2941, doi. 10.3892/ol.2015.3692
- By:
- Publication type:
- Article
Renal epithelial gene expression profile and bismuth-induced resistance against cisplatin nephrotoxicity.
- Published in:
- Human & Experimental Toxicology, 2003, v. 22, n. 10, p. 535, doi. 10.1191/0960327103ht393oa
- By:
- Publication type:
- Article
Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
- Published in:
- International Journal of Radiation Biology, 2004, v. 80, n. 4, p. 291, doi. 10.1080/09553000410001679767
- By:
- Publication type:
- Article
Lipoplatin Treatment in Lung and Breast Cancer.
- Published in:
- Chemotherapy Research & Practice, 2011, p. 1, doi. 10.1155/2011/125192
- By:
- Publication type:
- Article
Establishment of Stable hFis1 Knockdown Cells with an siRNA Expression Vector.
- Published in:
- Journal of Biochemistry, 2004, v. 136, n. 4, p. 421, doi. 10.1093/jb/mvh139
- By:
- Publication type:
- Article
Thermoanalytical study about histidine and cysteine-cadmium interactions.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2003, v. 74, n. 3, p. 923, doi. 10.1023/B:JTAN.0000011024.89077.43
- By:
- Publication type:
- Article
Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 97, n. 3, p. 393, doi. 10.1007/s11060-009-0033-z
- By:
- Publication type:
- Article
Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer.
- Published in:
- International Journal of Clinical Oncology, 2004, v. 9, n. 2, p. 85, doi. 10.1007/s10147-003-0369-x
- By:
- Publication type:
- Article
Protective Effects of Increasing Vitamin E and A Doses on Cisplatin-Induced Oxidative Damage to Kidney Tissue in Rats.
- Published in:
- Urologia Internationalis, 2005, v. 75, n. 4, p. 340, doi. 10.1159/000089171
- By:
- Publication type:
- Article
Magnetic properties of electrons in metal–ammonia solutions.
- Published in:
- Technical Physics, 1997, v. 42, n. 8, p. 855, doi. 10.1134/1.1258747
- By:
- Publication type:
- Article
Oxytocin alleviates cisplatin-induced renal damage in rats.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2014, v. 17, n. 10, p. 747
- By:
- Publication type:
- Article
Comparative Study Between Two Treatment Regimens of Cisplatin-5- Fluorouracil and Gemcitabine-Cisplatin in Gallbladder Cancer Patients.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2017, v. 16, n. 2, p. 795
- By:
- Publication type:
- Article
Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting.
- Published in:
- Patient Preference & Adherence, 2013, v. 7, p. 391, doi. 10.2147/PPA.S31288
- By:
- Publication type:
- Article
Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx.
- Published in:
- Head & Neck, 2014, v. 36, n. 5, p. 617, doi. 10.1002/hed.23339
- By:
- Publication type:
- Article
Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release
- Published in:
- Journal of Orthopaedic Research, 2004, v. 22, n. 4, p. 703, doi. 10.1016/j.orthres.2003.10.016
- By:
- Publication type:
- Article
Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1407, doi. 10.3390/ijms18071407
- By:
- Publication type:
- Article
A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 423, doi. 10.1186/1471-2407-12-423
- By:
- Publication type:
- Article
WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Low Temperature Synthesis of ZnNb2O6 Fine Powders by Wet-Chemical Processes.
- Published in:
- Ferroelectrics, 2009, v. 388, n. 1, p. 114, doi. 10.1080/00150190902965869
- By:
- Publication type:
- Article
Effect of Chemoradiotherapy with Gemcitabine and Cisplatin on Locoregional Control in Patients with Primary Inoperable Pancreatic Cancer.
- Published in:
- World Journal of Surgery, 2004, v. 28, n. 10, p. 1011, doi. 10.1007/s00268-004-7338-z
- By:
- Publication type:
- Article
Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer
- Published in:
- Otolaryngology-Head & Neck Surgery, 2004, v. 131, n. 4, p. 477, doi. 10.1016/j.otohns.2004.04.019
- By:
- Publication type:
- Article
Weekly paclitaxel, cisplatin, and radiation in advanced head and neck cancer (AHNC)
- Published in:
- 2004
- By:
- Publication type:
- Abstract
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 4, p. 915, doi. 10.1038/bjc.2013.432
- By:
- Publication type:
- Article
Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Phase I-II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
- Published in:
- British Journal of Cancer, 2004, v. 91, n. 4, p. 683, doi. 10.1038/sj.bjc.6602020
- By:
- Publication type:
- Article
Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells.
- Published in:
- 2004
- By:
- Publication type:
- journal article